JPMorgan Chase & Co. set a €110.00 ($123.60) price target on Merck KGaA (FRA:MRK) in a report released on Wednesday, Borsen Zeitung reports. The brokerage currently has a neutral rating on the healthcare company’s stock.

Several other research firms also recently issued reports on MRK. HSBC set a €101.00 ($113.48) target price on shares of Merck KGaA and gave the company a neutral rating in a research report on Monday, May 18th. DZ Bank reissued a buy rating on shares of Merck KGaA in a research report on Wednesday, July 22nd. Sanford C. Bernstein set a €115.00 ($129.21) target price on shares of Merck KGaA and gave the company a neutral rating in a research report on Monday, June 8th. Kepler Capital Markets set a €122.00 ($137.08) target price on shares of Merck KGaA and gave the company a sell rating in a research report on Wednesday, July 1st. Finally, Warburg Research set a €106.00 ($119.10) target price on shares of Merck KGaA and gave the company a neutral rating in a research report on Thursday, May 14th. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have issued a buy rating to the stock. The company currently has a consensus rating of Hold and an average price target of €108.64 ($122.07).

Merck KGaA stock opened at €108.05 ($121.40) on Wednesday. The business has a 50 day moving average of €107.71 and a 200-day moving average of €106.94. Merck KGaA has a 1 year low of €76.60 ($86.07) and a 1 year high of €115.00 ($129.21).

Merck KGaA Company Profile

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It offers prescription medicines to treat cancer, multiple sclerosis, infertility, growth deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, as well as squamous cell carcinoma of the head and neck; diagnostics and prescription drugs for allergen immunotherapy; and fertility treatments.

Further Reading: What is the S&P/ASX 200 Index?

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.